Protection levels in vaccinated heifers with experimental vaccines Brucella abortus M1-luc and INTA 2

Veterinary Microbiology

Volumn 132, Issue 3-4, 2008, Pages 302-311

  Fiorentino, M A ^a   Campos, E ^a   Cravero, S ^a   Arese, A ^a   Paolicchi, F ^a   Campero, C ^a   Rossetti, O ^a  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

Author keywords

Bovine; Brucella abortus; INTA 2; M1 luc; Vaccine

Indexed keywords

BRUCELLA ABORTUS INTA2 VACCINE; BRUCELLA ABORTUS M1 LUC VACCINE; BRUCELLA ABORTUS S19 VACCINE; BRUCELLA VACCINE; LIVE VACCINE; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG;

ABORTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BLOOD SAMPLING; BRUCELLA ABORTUS; BRUCELLOSIS; CALF (BOVINE); DRUG POTENCY; FEMALE; GESTATION PERIOD; HEIFER; HISTOPATHOLOGY; IMMUNITY; IMMUNOREACTIVITY; INOCULATION; NONHUMAN; PREGNANCY; PREMATURITY; SEROLOGY; VACCINATION;

ANIMALS; BACTERIAL VACCINES; BRUCELLA ABORTUS; BRUCELLOSIS, BOVINE; CATTLE; FEMALE;

BACTERIA (MICROORGANISMS); BOVINAE; BRUCELLA MELITENSIS BIOVAR ABORTUS; MUS;

EID: 53549111330     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2008.05.003     Document Type: Article

References (34)

1. Alton G.G., Jones L.M., Angus R.D., and Verger J.M. Techniques for The Brucellosis Laboratory (1988), INRA, Paris, France
2. Angus R., and Barton C. The production and evaluation of a buffered plate antigen for use in the presumptive test for brucellosis. Dev. Biol. Stand. 56 (1984) 349-356
3. Arese A.I., Cravero S.L., Boschiroli M.L., Campos E., Samartino L., and Rossetti O.L. Use of a recombinant protein from Brucella abortus for the diagnosis of brucellosis in different animal species. Rev. Argent. Microbiol. 31 (1999) 36-39
4. Boschiroli M.L., Cravero S.L., Arese A.I., Campos E., and Rossetti O.L. Protection against infection in mice vaccinated with a Brucella abortus mutant. Infect. Immun. 65 (1997) 798-800
5. Campero C.M., Moore D.P., Odeon A.C., Cipolla A.L., and Odriozola E. Aetiology of bovine abortion in Argentina. Vet. Res. Commun. 27 (2003) 359-369
6. Campos E., Cravero S.L., Delgui L., Mora I., Kahn N., Arese A.I., and Rossetti O.L. Brucella abortus INTA2, a novel strain 19 Δbp26::luc Δbmp18 double mutant lacking drug resistance markers. Vet. Microbiol. 87 (2002) 1-13
7. Cloeckaert A., Kerkhofs P., and Limet J.N. Antibody response to Brucella outer membrane proteins in bovine brucellosis: immunoblot analysis and competitive enzyme-linked immunosorbent assay using monoclonal antibodies. J. Clin. Microbiol. 30 (1992) 3168-3174
8. Cloeckaert A., Debbarh H.S., Vizcaino N., Saman E., Dubray G., and Zygmunt M.S. Cloning, nucleotide sequence, and expression of the Brucella melitensis bp26 gene coding for a protein immunogenic in infected sheep. FEMS Microbiol. Lett. 140 (1996) 139-144
9. Cloeckaert A., Baucheron S., Vizcaino N., and Zygmunt M.S. Use of recombinant BP26 in serological diagnosis of Brucella melitensis infection in sheep. Clin. Diagn. Lab. Immunol. 8 (2001) 772-775
10. Cloeckaert A., Jacques I., Grilló M.J., Marín C.M., Grayon M., Blasco J.M., and Verger J.M. Development and evaluation as vaccines in mice of Brucella melitensis Rev. 1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis. Vaccine 22 (2004) 2827-2835
11. Cheville N.F., Jensen A.E., Halling S.M., Tatum F.M., Mortiff D.C., Hennager S.G., Frerichs W.M., and Schurig G.G. Bacterial survival, lymph node changes, and immunologic responses of cattle vaccinated with standard and mutant strains of Brucella abortus. Am. J. Vet. Res. 53 (1992) 1881-1888
12. Cheville N.F., Stevens M.G., Jensen A.E., Tatum F.M., and Halling S.M. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus. Am. J. Vet. Res. 54 (1993) 1591-1597
13. Elzer P.H., Enright F.M., Colby L., Hagius S.D., Walker J.V., Fatemi M.B., et al. Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51. Am. J. Vet. Res. 59 (1998) 1575-1578
14. Godfroid J., Cloeckaert A., Liautard J.P., Kohler S., Fretin D., Walravens K., Garin-Bastuji B., and Letenson J.J. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet. Res. 36 (2005) 313-326
15. Guilloteau L.A., Laroucau K., Olivier M., Grillo M.J., Marin C.M., Verger J.M., and Blasco J.M. Residual virulence and immunogenicity of CGV26 and CGV2631 Brucella melitensis Rev.1 deletion mutant strains in sheep after subcutaneous or conjunctival vaccination. Vaccine 24 (2006) 3461-3468
16. Hemmen F., Weynants V., Scarcez T., Letesson J., and Saman E. Cloning and sequence analysis of a newly identified Brucella abortus gene and serological evaluation of the 17-kilodalton antigen that it encodes. Clin. Diagn. Lab. Immunol. 2 (1995) 263-267
17. Hsu S.M., Raine L., and Fanger H. The use of avidin biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29 (1981) 577-580
18. Hubbert W.T. Chairman. Committee on bovine reproductive nomenclature. Recommendations for standardizing bovine reproductive terms. Cornell Vet. 62 (1972) 216-237
19. Jacques I., Verger J.-M., Laroucau K., Grayon M., Vizcaino N., Peix A., Cortade F., Carreras F., and Guilloteau L.A. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev. 1 deletion mutants in sheep. Vaccine 25 (2007) 794-805
20. Limet J.N., Cloeckaert A., Dezard G., Van Broeck J., and Dubray G. Antibody response to the 89 kDa outer membrane protein of Brucella in bovine brucellosis. J. Med. Microbiol. 39 (1993) 403-407
21. Linder L.E., Hadfield T.L., Tall B.D., Snellings N.J., Rubin F.A., Van De Verg L.L., Hoover D., and Warren R.L. Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis. Infect. Immun. 64 (1996) 2490-2499
22. López A., Hitos F., Perez A., and Navarro-Fierro R.R. Lung lesions in bovine fetuses aborted by Brucella abortus. Can. J. Comp. Med. 48 (1984) 275-277
23. Mortimer R.G., Farin P.W., and Stevens R.D. Bovine Theriogenology Chapter 33. Reproductive examination of the non-pregnant cow. In: Youngquist R.S. (Ed). Current Therapy in Large Animal Theriogenology (1997), WB Saunders Company. Press, Philadelphia, PA, USA 268-275
24. Nielsen K. Diagnosis of brucellosis by serology. Vet. Microbiol. 90 (2002) 447-459
25. Pappas G., Papadimitriou P., Akritidis N., Christou L., and Tsianos V.E. The new global map of human brucellosis. Lancet Infect. Dis. 6 (2006) 91-99
26. Poester F.P., Gonçalves V.S.P., Paixão T.A., Santos S.C., Olsen R.L., Schurig G.G., and Lage A.P. Efficacy of strain RB51 vaccine in heifers against experimental brucellosis. Vaccine 24 (2006) 5327-5334
27. Rossetti O.L., Boschiroli M.L., Arese A.I., and Cravero S.L. Cloning of Brucella abortus gene and characterization of expressed 26-kilodalton periplasmic protein: potential use for diagnosis. J. Clin. Microbiol. 34 (1996) 165-169
28. Schurig G.G., Roop R.M., Bagchi T., Boyle S., and Sriranganathan N. Biological properties of RB51: a stable rough strain of Brucella abortus. Vet. Microbiol. 28 (1991) 171-188
29. Sözmen M., Erginsoy S.D., Genç O., Beytut E., and Özcan K. Immunohistochemical and microbiological detection of Brucella abortus in aborted bovine fetuses. Acta Vet. Brno 73 (2004) 465-472
30. Tabatabai L.B., and Hennager S.G. Cattle serologically positive for Brucella abortus have antibodies to B. abortus Cu-Zn superoxide dismutase. Clin. Diagn. Lab. Immunol. 1 (1994) 506-510
31. Terzolo H.R., Paolicchi F.A., Moreira A.R., and Homse A. Skirrow agar for simultaneous isolation of Brucella and Campylobacter species. Vet. Rec. 129 (1991) 531-532
32. Tibor A., Saman E., de Wergifosse P., Cloeckert A., Limet J.N., and Letteson J.J. Molecular characterization, occurrence, and immunogenicity in infected sheep and cattle of two minor outer membrane proteins of Brucella abortus. Infect. Immun. 64 (1996) 100-107
33. Vemulapalli R., Cravero S., Calvert C.L., Toth T.E., Sriranganathan N., Boyle S.M., Rossetti O.L., and Schurig G.G. Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus. Clin. Diagn. Lab. Immunol. 7 (2000) 114-118
34. World Health Organization (WHO), 1997. Report of the WHO Working Group meeting on Brucellosis control and research: The development of new/improved Brucellosis vaccines. http://www.who.int/emc.